We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study.
- Authors
Papp, Kim A.; Lebwohl, Mark G.; Thaçi, Diamant; Jaworski, Janusz; Kwiek, Bartlomiej; Trefler, Jakub; Dudek, Anna; Szepietowski, Jacek C.; Reznichenko, Nataliya; Narbutt, Joanna; Baran, Wojciech; Kolinek, Joanna; Daniluk, Stefan; Bartnicka-Maslowska, Katarzyna; Reich, Adam; Andrashko, Yuriy; Kim, Sunghyun; Bae, Yunju; Jeon, Dabee; Jung, Jinsun
- Publication
BioDrugs, 2024, Vol 38, Issue 1, p121
- ISSN
1173-8804
- Publication type
Article
- DOI
10.1007/s40259-023-00630-5